Nasopharyngeal carcinoma epidemiology and demographics

Jump to: navigation, search

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma epidemiology and demographics

CDC on Nasopharyngeal carcinoma epidemiology and demographics

Nasopharyngeal carcinoma epidemiology and demographics in the news

Blogs on Nasopharyngeal carcinoma epidemiology and demographics

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in the USA. Patients of all age groups may develop nasopharyngeal carcinoma.

Epidemiology

Age

Patients of all age groups may develop nasopharyngeal carcinoma.

Gender

Nasopharyngeal carcinoma affects men and women equally.

Race

Nasopharyngeal carcinoma usually affects individuals of the Far Eastern (e.g. Chinese) ethnicity.

Demographics

  • The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in the USA.[1]
  • Nasopharyngeal carcinomas account for approximately 70% of all primary malignancies of the nasopharynx.
  • Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China.[2][3][4]

References

  1. "Initiative for Vaccine Research (IVR): Viral cancers". World Health Organization. Retrieved 2 October 2012. 
  2. http://radiopaedia.org/articles/nasopharyngeal-carcinoma
  3. Fang W, Li X, Jiang Q, (2008). "Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China". J Transl Med. 6: 32. PMC 2443113Freely accessible. PMID 18570662. doi:10.1186/1479-5876-6-32. 
  4. Chang E T, Adami H (2006). "The Enigmatic Epidemiology of Nasopharyngeal Carcinoma". Cancer Epidemiol Biomarkers Prev. 15 (10): 1765–1777. PMID 17035381. doi:10.1158/1055-9965.EPI-06-0353. 

Linked-in.jpg